- Home
- GPCR vs SONO Comparison
GPCR vs SONO Comparison
Compare GPCR & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- SONO
- Stock Information
- Founded
- GPCR 2016
- SONO 2002
- Country
- GPCR United States
- SONO United States
- Employees
- GPCR N/A
- SONO N/A
- Industry
- GPCR
- SONO Consumer Electronics/Video Chains
- Sector
- GPCR
- SONO Consumer Discretionary
- Exchange
- GPCR Nasdaq
- SONO Nasdaq
- Market Cap
- GPCR 1.8B
- SONO 1.4B
- IPO Year
- GPCR 2023
- SONO 2018
- Fundamental
- Price
- GPCR $34.17
- SONO $13.05
- Analyst Decision
- GPCR Buy
- SONO Buy
- Analyst Count
- GPCR 5
- SONO 2
- Target Price
- GPCR $86.80
- SONO $17.50
- AVG Volume (30 Days)
- GPCR 677.5K
- SONO 1.9M
- Earning Date
- GPCR 11-13-2024
- SONO 11-13-2024
- Dividend Yield
- GPCR N/A
- SONO N/A
- EPS Growth
- GPCR N/A
- SONO N/A
- EPS
- GPCR N/A
- SONO N/A
- Revenue
- GPCR N/A
- SONO $1,518,056,000.00
- Revenue This Year
- GPCR N/A
- SONO N/A
- Revenue Next Year
- GPCR N/A
- SONO $14.58
- P/E Ratio
- GPCR N/A
- SONO N/A
- Revenue Growth
- GPCR N/A
- SONO N/A
- 52 Week Low
- GPCR $26.61
- SONO $10.23
- 52 Week High
- GPCR $66.38
- SONO $19.76
- Technical
- Relative Strength Index (RSI)
- GPCR 35.81
- SONO 48.49
- Support Level
- GPCR $33.85
- SONO $13.45
- Resistance Level
- GPCR $38.48
- SONO $15.89
- Average True Range (ATR)
- GPCR 2.62
- SONO 0.66
- MACD
- GPCR -0.36
- SONO -0.01
- Stochastic Oscillator
- GPCR 3.67
- SONO 18.39
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About SONO Sonos Inc.
Sonos Inc is engaged in providing home sound systems. The company's product profile includes speaker sets and other accessories like boost, mounts, stands, and cables and networking. Geographically, the company operates in the Americas, Europe, the Middle East and Africa, and the Asia Pacific. Generating a majority of its revenue from the Americas.